| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Regular Article |
a BIOQUAL, Inc., Rockville, Maryland 20850
b Department of Experimental Radiation Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas 77030
c Contraception and Reproductive Health Branch (CRHB), National Institute of Child Health and Human Development (NICHD), Rockville, Maryland 20852
ABSTRACT
The goals of this study were to determine the CDB-4022 dose-response relationship for induction of acute decreases in testicular weight and germ cell depopulation in rats; establish the threshold dose of CDB-4022 required to induce infertility; and investigate whether CDB-4022-induced testicular damage could be prevented by a GnRH agonist (Lupron Depot). Reduction of testis weight and germ cell depopulation were observed 7 days after a single oral dose of 1 mg CDB-4022/kg, whereas 0.5 mg/kg had no observable effect. These effects were maximal at 12.5 or 25 mg CDB-4022/kg. After a single oral dose of either 2.5 or 5 mg/kg, CDB-4022 induced infertility in five of five treated rats by Week 5, whereas only one of five males was rendered infertile at a dose of 1 mg/kg. Proven fertile male rats (6/group) were treated with vehicle, CDB-4022 alone (2.5 mg/kg on Day 0), CDB-4022 plus Lupron Depot (on Weeks -1, 2, 5, and 8), or Lupron Depot alone. Control males demonstrated normal fertility throughout a 32-wk cohabitation period. Five of six rats were rendered transiently infertile with Lupron Depot alone, but all recovered fertility. CDB-4022 treatment resulted in infertility in all six rats, and only one of six regained fertility. Combined treatment also caused infertility in all six rats, but four of six recovered fertility (P = 0.08 compared to CDB-4022 alone). Testicular weight was decreased in the three treatment groups compared to vehicle controls; testicular weights were ranked from highest to lowest as follows: vehicle > Lupron Depot > Lupron Depot + CDB-4022 > CDB-4022. The tubule differentiation index of Lupron Depot-treated rats (96 ± 4%) was not different from vehicle-treated rats (100%). CDB-4022 treatment decreased the number of differentiating tubules (15 ± 8%). Lupron Depot plus CDB-4022 treatment resulted in a greater number of differentiating tubules (53 ± 12%) than CDB-4022 alone, but this was still lower than vehicle- or Lupron Depot-treated rats. These data indicate that 2.5 mg/kg of CDB-4022 was the oral threshold dose that caused testicular damage rendering the majority of adult male rats permanently infertile within the study interval; 12.5 mg/kg of CDB-4022 induced maximal testicular damage. Suppression of gonadotropins and/or testosterone production by treatment with Lupron Depot before and after CDB-4022 prevented the CDB-4022-induced irreversible testicular damage.
First decision: 6 December 2000.
1 This work was supported by National Institute of Child Health and Human Development (NICHD) contract N01-HD-6-3259 awarded to BIOQUAL, Inc. A portion of this work was presented at the XIVth Testis Workshop: Germ Cell Development, Division, Disruption and Death (1997) Abstract I-32.
2 Correspondence: Sheri Hild, BIOQUAL, Inc., 9600 Medical Center Dr., Rockville, MD 20850. FAX: 301 251 1260; sahild{at}compuserve.com
This article has been cited by other articles:
|
|
 |
|
  M. L Meistrich and G. Shetty Hormonal suppression for fertility preservation in males and females Reproduction, December 1, 2008; 136(6): 691 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Koduri, S. A. Hild, L. Pessaint, J. R. Reel, and B. J. Attardi Mechanism of Action of l-CDB-4022, a Potential Nonhormonal Male Contraceptive, in the Seminiferous Epithelium of the Rat Testis Endocrinology, April 1, 2008; 149(4): 1850 - 1860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-C. Chen, R. K Cochrum, M. T Tseng, D. T Ghooray, J. P Moore, S. J Winters, and B. J Clark Effects of CDB-4022 on Leydig Cell Function in Adult Male Rats Biol Reprod, December 1, 2007; 77(6): 1017 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Hild, J. R. Reel, M. J. Dykstra, P. C. Mann, and G. R. Marshall Acute Adverse Effects of the Indenopyridine CDB-4022 on the Ultrastructure of Sertoli Cells, Spermatocytes, and Spermatids in Rat Testes: Comparison to the Known Sertoli Cell Toxicant Di-n-pentylphthalate (DPP) J Androl, July 1, 2007; 28(4): 621 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Hild, G. R. Marshall, B. J. Attardi, R. A. Hess, S. Schlatt, D. R. Simorangkir, S. Ramaswamy, S. Koduri, J. R. Reel, and T. M. Plant Development of l-CDB-4022 as a Nonsteroidal Male Oral Contraceptive: Induction and Recovery from Severe Oligospermia in the Adult Male Cynomolgus Monkey (Macaca fascicularis) Endocrinology, April 1, 2007; 148(4): 1784 - 1796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Hild, B. J. Attardi, and J. R. Reel The Ability of a Gonadotropin-Releasing Hormone Antagonist, Acyline, to Prevent Irreversible Infertility Induced by the Indenopyridine, CDB-4022, in Adult Male Rats: The Role of Testosterone Biol Reprod, July 1, 2004; 71(1): 348 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Meistrich, G. Wilson, K. L. Porter, I. Huhtaniemi, G. Shetty, and G. A. Shuttlesworth Restoration of Spermatogenesis in Dibromochloropropane (DBCP)-Treated Rats by Hormone Suppression Toxicol. Sci., December 1, 2003; 76(2): 418 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Meistrich and G. Shetty Inhibition of Spermatogonial Differentiation by Testosterone J Androl, March 1, 2003; 24(2): 135 - 148. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
